top of page
Articles
Biotechs are Accelerating Drug Discovery by Repurposing Platforms: What This Means for Investors
August 23, 2023
Some up-and-coming drugmakers are capitalizing on a new trend in the space that's helping them dramatically reduce the time and expense involved in new drug development.
These Are the Five Best-Performing Biotech IPOs from H2 2022
September 12, 2023
Here are the top five performers among the biotech firms that went public during the second half of 2022, meaning they've been public for about a year or nearly a year.
Why Biotech Is the Next Frontier for Impact Investing
February 16, 2024
A growing number of investors think biotech does have an important place in the world of impact investing.
Read 5 Biotech stocks tapping into unmet mental health treatment needs
December 20, 2023
A growing number of biotechnology companies are giving patients new hope for recovery and the ability to thrive.
These Five Biotech Stocks Are Developing Potentially Groundbreaking Mental Health Treatments
November 10, 2023
Discuss biotech companies that are working on groundbreaking treatments for post-traumatic stress disorder (PTSD) and other mental health concerns.
5 Gene Therapy Companies That May Transform the Medical Industry
May 24, 2023
The gene therapy field is growing dramatically and is expected by many to be the future of medicine for a myriad of diseases.
How these Biotech Companies have been Exploring the Potential of Cannabinoids Before and after the MMCREA
April 11, 2024
Biotechnology companies and the medical-marijuana industry are awaiting some critical updates in the wake of the Medical Marijuana and Cannabidiol Research Expansion Act (MMCREA).
How This New and Emerging Business Model Is Changing the Face of Biotech Today
February 12, 2024
This model of developing one product or technology at a time allows for focus, some biotech executives believe it’s a very high-risk proposition for investors.
These Biotechs targeting multiple neurodegenerative diseases
December 1, 2023
A growing number of up-and-coming biotech firms aim to flip the script on this issue by searching for new types of treatments that target the root causes of these NDDs.
Protalix: Leveraging Tech In Developing Therapies For Orphan Diseases
June 18, 2024
Protalix has been leveraging its proprietary ProCellEx® platform, which is the key to the company’s production of complex and biologically similar proteins with a major focus on treating rare human diseases.
These Four Biotech Stocks Tap into the Impact-Investing Movement
March 13, 2024
A closer look at certain biotech companies does suggest that they could be great additions to an impact-investment portfolio.
Here Are Four Small-Cap Stocks in Honor of World Cancer Day
March 4, 2024
Feb. 4 was World Cancer Day, so this month is a great time to look at the stocks of some companies that are working on treatments for different types of cancer.
bottom of page